During the past decade, Cetus Oncologia conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cetus Oncologia" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored and "Sumitomo Pharma Oncology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cetus Oncologia" #1 collaborator was "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator, "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator and "Fundación GECP" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Cetus Oncologia" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Cancer" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Cetus Oncologia" in a lesser frequency.

Most popular intervention types in "Cetus Oncologia" are "Drug" (13 trials), "Other" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (4 trials), "Amivantamab" (3 trials), "Atezolizumab" (3 trials) and "Lazertinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cetus Oncologia" are 11 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Cetus Oncologia". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cetus Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cetus Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".